BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37689710)

  • 1. EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis.
    Wu CS; Chien YC; Yen CJ; Wu JY; Bai LY; Yu YL
    Cancer Cell Int; 2023 Sep; 23(1):199. PubMed ID: 37689710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lin28B over-expression mediates the repression of let-7 by hepatitis B virus X protein in hepatoma cells.
    Wu G; Huang P; Ju X; Li Z; Wang Y
    Int J Clin Exp Med; 2015; 8(9):15108-16. PubMed ID: 26628994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
    Wang Y; Lu Y; Toh ST; Sung WK; Tan P; Chow P; Chung AY; Jooi LL; Lee CG
    J Hepatol; 2010 Jul; 53(1):57-66. PubMed ID: 20447714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
    Yao Y; Zhang C; Xiong Y; Han B; Gao X; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1022-1029. PubMed ID: 34308851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma.
    Shi T; Hua Q; Ma Z; Lv Q
    Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cell line HCCLM3 by targeting HMGA2.
    Zha Y; Yao Q; Liu JS; Wang YY; Sun WM
    Oncol Lett; 2018 Nov; 16(5):5709-5714. PubMed ID: 30356986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
    Huang FY; Wong DK; Mak LY; Cheung TT; Seto WK; Yuen MF
    Carcinogenesis; 2022 Aug; 43(7):671-681. PubMed ID: 35353897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
    Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
    Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lin28B Regulates Angiotensin II-Mediated Let-7c/miR-99a MicroRNA Formation Consequently Affecting Macrophage Polarization and Allergic Inflammation.
    Jaiswal A; Maurya M; Maurya P; Barthwal MK
    Inflammation; 2020 Oct; 43(5):1846-1861. PubMed ID: 32458348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma.
    Zhou P; Yao W; Liu L; Yan Q; Chen X; Wei X; Ding S; Lv Z; Zhu F
    Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38753154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.
    Liang HW; Wang N; Wang Y; Wang F; Fu Z; Yan X; Zhu H; Diao W; Ding Y; Chen X; Zhang CY; Zen K
    J Hepatol; 2016 Feb; 64(2):278-291. PubMed ID: 26409216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
    Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
    Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
    [No Abstract]   [Full Text] [Related]  

  • 20. Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma.
    Shi W; Zhang Z; Yang B; Guo H; Jing L; Liu T; Luo Y; Liu H; Li Y; Gao Y
    Medicine (Baltimore); 2017 Aug; 96(32):e7764. PubMed ID: 28796071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.